Nephros (NEPH)
(Delayed Data from NSDQ)
$2.19 USD
0.00 (0.00%)
Updated Apr 24, 2024 03:59 PM ET
After-Market: $2.14 -0.05 (-2.28%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Nephros Inc. [NEPH]
Reports for Purchase
Showing records 1 - 18 ( 18 total )
Company: Nephros Inc.
Industry: Medical - Products
Company: Nephros Inc.
Industry: Medical - Products
Discontinuing coverage due to termination of research services
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Company: Nephros Inc.
Industry: Medical - Products
Maintaining our Speculative Buy rating but reducing our 12-month price target to $9.75 per share.
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Company: Nephros Inc.
Industry: Medical - Products
Maintaining our Speculative Buy rating but reducing our 12-month price target to $11.00 per share
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Company: Nephros Inc.
Industry: Medical - Products
Maintaining our Speculative Buy rating but reducing our 12-month price target to $13.50 per share from $15.50 per share
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Company: Nephros Inc.
Industry: Medical - Products
Maintaining Speculative Buy rating and 12-month price target of $15.50 per share.
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Company: Nephros Inc.
Industry: Medical - Products
Maintaining Speculative Buy rating and 12-month price target of $15.50 per share.
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Company: Nephros Inc.
Industry: Medical - Products
Maintaining Speculative Buy rating and increasing our 12-month price target.
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Company: Nephros Inc.
Industry: Medical - Products
Maintaining Speculative Buy rating and increasing our 12-month price target to $10.00 per share from $9.00* per share
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Company: Nephros Inc.
Industry: Medical - Products
Maintaining Speculative Buy rating and 12-month price target of $1.00 per share.
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Company: Nephros Inc.
Industry: Medical - Products
Initiating Nephros, Inc., with a Speculative Buy rating and 12-month price target of $1.00 per share.
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Company: Nephros Inc.
Industry: Medical - Products
Company: Nephros Inc.
Industry: Medical - Products
Company: Nephros Inc.
Industry: Medical - Products
Company: Nephros Inc.
Industry: Medical - Products
Company: Nephros Inc.
Industry: Medical - Products
Company: Nephros Inc.
Industry: Medical - Products
After a pause in 3Q15, Nephros expects a return to growth
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
Company: Nephros Inc.
Industry: Medical - Products
|